- Home
- APLT vs AMSF Comparison
APLT vs AMSF Comparison
Compare APLT & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AMSF
- Stock Information
- Founded
- APLT 2016
- AMSF 1985
- Country
- APLT United States
- AMSF United States
- Employees
- APLT N/A
- AMSF N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- APLT Health Care
- AMSF Finance
- Exchange
- APLT Nasdaq
- AMSF Nasdaq
- Market Cap
- APLT 63.6M
- AMSF 857.2M
- IPO Year
- APLT 2019
- AMSF 2005
- Fundamental
- Price
- APLT $0.42
- AMSF $43.06
- Analyst Decision
- APLT Buy
- AMSF Buy
- Analyst Count
- APLT 6
- AMSF 2
- Target Price
- APLT $6.10
- AMSF $57.50
- AVG Volume (30 Days)
- APLT 876.2K
- AMSF 73.6K
- Earning Date
- APLT 11-06-2025
- AMSF 10-22-2025
- Dividend Yield
- APLT N/A
- AMSF 10.62%
- EPS Growth
- APLT N/A
- AMSF N/A
- EPS
- APLT N/A
- AMSF 2.63
- Revenue
- APLT $121,000.00
- AMSF $306,470,000.00
- Revenue This Year
- APLT N/A
- AMSF $2.98
- Revenue Next Year
- APLT $5,931.24
- AMSF $5.32
- P/E Ratio
- APLT N/A
- AMSF $16.33
- Revenue Growth
- APLT N/A
- AMSF N/A
- 52 Week Low
- APLT $0.30
- AMSF $42.48
- 52 Week High
- APLT $10.62
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- APLT 38.07
- AMSF 34.23
- Support Level
- APLT $0.43
- AMSF $44.65
- Resistance Level
- APLT $0.46
- AMSF $46.53
- Average True Range (ATR)
- APLT 0.03
- AMSF 0.98
- MACD
- APLT -0.01
- AMSF -0.33
- Stochastic Oscillator
- APLT 11.08
- AMSF 4.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.